Negotiating excess treatment costs in a clinical research trial: the good, the bad and the innovative

ABSTRACT: Barriers to recovering the excess treatment costs associated with health research from local organisations in the United Kingdom can increase research costs, delay completion of high- quality studies and risk disenfranchising health trusts and patients from participation. The authors demon...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmer, Rebecca, Harrison, Madeleine, Cross, Elizabeth, Enderby, Pam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748533/
https://www.ncbi.nlm.nih.gov/pubmed/26860107
http://dx.doi.org/10.1186/s13063-016-1208-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748533/
https://www.ncbi.nlm.nih.gov/pubmed/26860107
http://dx.doi.org/10.1186/s13063-016-1208-5

Ejemplares similares